A study to compare the duration of pain free period after surgery when Butorphanol and Tramadol given with Levobupivacaine in brachial plexus block
- Conditions
- Unspecified fracture of forearm,
- Registration Number
- CTRI/2022/04/041666
- Lead Sponsor
- Dr Jaya Lalwani
- Brief Summary
This is a prospective observational study to see the duration of postoperative analgesia when Butorphanol and Tramadol given with Levobupivacaine for brachial plexus block in patients undergoing below elbow upper limb surgery aged 18 to 65 years with ASA grade I to III. It will be conducted at single centre in India. The primary outcome will be duration of postoperative analgesia and secondary outcomes will be assessment of pain using VAS, onset and duration of sensory and motor blockade and monitoring associated symptoms like allergic reactions, nausea, vomiting, pneumothorax, Horner’s syndrome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 100
- ASA grade I to III 2.
- Patients undergoing elective below elbow upper limb surgery under ultra sound guided supraclavicular brachial plexus block.
- Patient refusal 2.
- Local infection at injection site 3.
- Failure of block 4.
- Any bleeding disorder and patient on anticoagulants 5.
- Allergy to study drugs 6.
- Severe respiratory, renal and liver disorder 7.
- Glucose intolerance and diabetic patient 8.
- Neurological deficit involving brachial plexus 9.
- Morbidly obese 10.
- Pregnant women 11.
- Drug abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of postoperative analgesia First 24 hours of postoperative period
- Secondary Outcome Measures
Name Time Method ⮚ Assessment of pain using VAS ⮚ Onset of sensory and motor blockade
Trial Locations
- Locations (1)
Dr Bhimrao Ambedkar Memorial Hospital RaipurPt
🇮🇳Raipur, CHHATTISGARH, India
Dr Bhimrao Ambedkar Memorial Hospital RaipurPt🇮🇳Raipur, CHHATTISGARH, IndiaDr Ravi ChaudhariPrincipal investigator8308422897ravichaudharicc@gmail.com